<aside> <img src="https://prod-files-secure.s3.us-west-2.amazonaws.com/ae1996a8-7c2b-44c5-a5fb-1e85ffb4fc8d/f7d827c6-baca-47e2-bcf9-c80b4aff44c8/Bioentesi_logo.jpg" alt="https://prod-files-secure.s3.us-west-2.amazonaws.com/ae1996a8-7c2b-44c5-a5fb-1e85ffb4fc8d/f7d827c6-baca-47e2-bcf9-c80b4aff44c8/Bioentesi_logo.jpg" width="40px" /> The Bioentesi start-up project aims to improve orthopedic practice by making a gelatinous coating to be applied to screws used in orthopedics as part of ligament or tendon reconstruction surgeries.
</aside>
The Anterior Cruciate Ligament (ACL) represents a crucial structure within the knee joint. on which the stability of the joint depends and is a structure involved in many daily movements. This important and continuous involvement in movements makes it a ligament highly susceptible to rupture during physical activities.
When the ACL sustains significant damage, it sets off a chain reaction of chronic health problems, including the premature onset of osteoarthritis, joint instability, meniscal tears and general joint dysfunction. In light of these multifactorial consequences, medical consensus generally leans towards promoting ACL reconstruction surgery.
Unfortunately:
<aside> <img src="/icons/cursor-click_blue.svg" alt="/icons/cursor-click_blue.svg" width="40px" /> Bioenthesis aims to improve the outcome of current ACL operations, through a medical device characterized by a collagen hydrogel matrix, to be used as a covering for the bioabsorbable screw placed in position during normal ligament reconstruction surgery. This innovative coating will be designed to create a more favorable interface between the screw and the bone, which will allow cells to migrate and find a preferable material to colonize and recreate a more natural-like enthesis (bone-ligament interface).
</aside>
<aside> <img src="/icons/city_blue.svg" alt="/icons/city_blue.svg" width="40px" /> TAM 42 MLN (SPORTS PEOPLE AND OVER 65)
</aside>
<aside> <img src="/icons/city_blue.svg" alt="/icons/city_blue.svg" width="40px" /> SAM 38 MLN (SPORTS PEOPLE)
</aside>
<aside> <img src="/icons/city_blue.svg" alt="/icons/city_blue.svg" width="40px" /> SOM 1,14 MLN (Every year 3% of amateur athletes suffer an anterior cruciate ligament injury)
</aside>
In progress…
We are a dedicated team of innovators and experts, combining diverse experiences and skills to drive innovation. Our passion, combined with our deep expertise in technology and business strategy, uniquely positions us to address the complex challenges of the biomedical industry. With an ongoing commitment to research and development, we are at the forefront of creating cutting-edge solutions that improve the quality of life. Our ability to integrate interdisciplinary knowledge enables us to develop breakthrough technologies, providing effective and sustainable answers to emerging healthcare needs.